ABBV-154
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ABBV-154, covering 2024-10-03 to 2024-10-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154 [Phase 2]